sodium channel, voltage-gated, type IX, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type IV, beta |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type III, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type II, beta |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type I, beta |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type I, alpha |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type IV, beta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel associated protein 1 |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel associated protein 2 |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type III, beta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type I, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type III, beta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type I, beta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type II, beta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type X, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type IV, beta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
phosphodiesterase 4C, cAMP-specific |
GENISTEIN |
Phosphodiesterase PDE4 |
74% |
10.924uM |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type II, beta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type I, beta |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type I, alpha |
DOMPERIDONE |
Sodium Channel, Site 2 |
100% |
1.035uM |
.944uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type X, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type IV, beta |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type III, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type II, beta |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type I, beta |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type I, alpha |
FLUNARIZINE |
Sodium Channel, Site 2 |
100% |
.263uM |
.24uM |
View
|
sodium channel, voltage-gated, type IV, beta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel associated protein 1 |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel associated protein 2 |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type III, beta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type I, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type III, beta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type I, beta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type II, beta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type X, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type IV, beta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type III, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type II, beta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type I, beta |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type I, alpha |
TERFENADINE |
Sodium Channel, Site 2 |
100% |
.078uM |
.071uM |
View
|
sodium channel, voltage-gated, type IV, beta |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel associated protein 1 |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel associated protein 2 |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
sodium channel, voltage-gated, type III, beta |
CINNARIZINE |
Sodium Channel, Site 2 |
100% |
.414uM |
.377uM |
View
|
estrogen receptor 1 |
GENISTEIN |
Estrogen ERbeta |
105% |
.00288uM |
.000594uM |
View
|
estrogen receptor 1 |
GENISTEIN |
Estrogen ERbeta |
105% |
.00288uM |
.000594uM |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
TOPOTECAN |
CYP450-3A4 Inhibition |
100% |
1.5211uM |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
EBASTINE |
Potassium Channel HERG |
100% |
.1048uM |
.0858uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
EBASTINE |
Potassium Channel HERG |
100% |
.1048uM |
.0858uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
EBASTINE |
Potassium Channel HERG |
100% |
.1048uM |
.0858uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
EBASTINE |
Potassium Channel HERG |
100% |
.1048uM |
.0858uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
EBASTINE |
Potassium Channel HERG |
100% |
.1048uM |
.0858uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
EBASTINE |
Potassium Channel HERG |
100% |
.1048uM |
.0858uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
EBASTINE |
Potassium Channel HERG |
100% |
.1048uM |
.0858uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
EBASTINE |
Potassium Channel HERG |
100% |
.1048uM |
.0858uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
EBASTINE |
Potassium Channel HERG |
100% |
.1048uM |
.0858uM |
View
|
sodium channel, voltage-gated, type I, beta |
PERHEXILINE |
Sodium Channel, Site 2 |
100% |
.5106uM |
.4658uM |
View
|
sodium channel, voltage-gated, type I, alpha |
PERHEXILINE |
Sodium Channel, Site 2 |
100% |
.5106uM |
.4658uM |
View
|
sodium channel, voltage-gated, type IV, beta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel associated protein 1 |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel associated protein 2 |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type III, beta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type I, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type III, beta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
phosphodiesterase 4D |
GENISTEIN |
Phosphodiesterase PDE4 |
74% |
10.924uM |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type I, beta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type II, beta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type X, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type IV, beta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type III, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type II, beta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type I, beta |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
sodium channel, voltage-gated, type I, alpha |
SULOCTIDIL |
Sodium Channel, Site 2 |
100% |
.1749uM |
.1596uM |
View
|
tachykinin receptor 2 |
HEXACHLOROPHENE |
Tachykinin NK2 |
100% |
4.1392uM |
1.3797uM |
View
|
histamine receptor H 2 |
SULOCTIDIL |
Histamine H2 |
100% |
.1081uM |
.0885uM |
View
|
epidermal growth factor receptor |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Protein Tyrosine Kinase, EGF Receptor |
100% |
1.0633uM |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Protein Tyrosine Kinase, Fyn |
100% |
.5645uM |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
BW-723C86 |
Serotonin 5-HT2B |
100% |
.0811uM |
.0516uM |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
AMIODARONE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
AMIODARONE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
AMIODARONE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
AMIODARONE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
AMIODARONE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
AMIODARONE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
AMIODARONE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
AMIODARONE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
AMIODARONE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
TERFENADINE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
TERFENADINE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
TERFENADINE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
TERFENADINE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
TERFENADINE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
TERFENADINE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
TERFENADINE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
TERFENADINE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
TERFENADINE |
Potassium Channel HERG |
100% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
SULOCTIDIL |
Calcium Channel Type L, Dihydropyridine |
100% |
.2595uM |
.1668uM |
View
|